NORTHERN TRUST CORP - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 12 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q3 2023$17,748
-25.8%
19,9330.0%0.00%
Q2 2023$23,920
-25.5%
19,9330.0%0.00%
Q1 2023$32,092
+34.2%
19,9330.0%0.00%
Q4 2022$23,920
-8.0%
19,933
+29.6%
0.00%
Q3 2022$26,000
+100.0%
15,3760.0%0.00%
Q2 2022$13,000
-23.5%
15,3760.0%0.00%
Q1 2022$17,000
-43.3%
15,3760.0%0.00%
Q4 2021$30,00015,3760.00%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q3 2022
NameSharesValueWeighting ↓
Mayo Clinic 181,754$161,8340.31%
PERKINS CAPITAL MANAGEMENT INC 150,000$1340.13%
Nantahala Capital Management 1,250,000$1,113,0000.10%
Princeton Global Asset Management LLC 16,833$14,9880.00%
MAI Capital Management 50,000$44,5200.00%
SG Americas Securities, LLC 50,453$450.00%
Walleye Capital LLC 225,956$201,1910.00%
UBS Group AG 108$960.00%
NewEdge Advisors, LLC 2,380$2,1190.00%
OSAIC HOLDINGS, INC. 700$6230.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders